A recent study and accompanying news story in the preeminent journal Nature provocatively concludes that disruptive innovation in science has dramatically and mysteriously declined 90% since 1945, but has it really?...
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for Moderna’s investigational mRNA vaccine for respiratory syncytial virus (RSV) in adult patients....
National Cancer Institute reviewers found that the UW Carbone Cancer Center’s six program areas were rated 'outstanding' or 'outstanding to exceptional'....
Predictive analytics, the use of data, algorithms and visualizations to forecast outcomes, is being increasingly used in drug development and clinical trial design....
The NIH explores ways to speed up the research and discovery of new treatments for rare diseases, which are not often thought of as the public health challenge that they are. ...
Following a year filled with several approvals for rare disease drugs, experts are expecting this trend to continue in 2023....
The FDA recently released guidance related to clinical research on human drugs containing cannabis or cannabis-derived compounds....
Exploring ways clinical trial leaders and organizers can improve the patient experience....
Experts share why protection by the exclusion of pregnant people leads to a lack of evidence-based medicine and ways to improve clinical trial conduct....
After completing difficult bouts of chemotherapy, Larson contacted the UW Health | Carbone Cancer Center to see which clinical trials he could explore....
